Novo Nordisk is expanding its manufacturing facility in Athlone, Ireland, to produce the oral version of its Wegovy weight-loss pill for markets outside the U.S.12346
CEO Mike Doustdar confirmed the expansion but did not disclose the investment amount or timeline.124
The Wegovy pill launched in the U.S. in early January, with over 240,000 patients already using it.12
U.S. supply is manufactured domestically, while the Irish site targets international demand.13
The expansion supports Novo Nordisk's efforts amid competition in the obesity drug market.12
Sources:
1. https://stocktwits.com/news-articles/markets/equity/novo-looks-to-ireland-to-scale-production-of-wegovy-pill-report/cZRT0F6R4rc
2. https://www.siliconrepublic.com/business/novo-nordisk-plans-irish-manufacturing-expansion-for-wegovy
3. https://www.fiercepharma.com/manufacturing/amid-wegovy-pills-flying-start-us-doustdar-eyes-ireland-expansion-supply-overseas
4. https://www.irishtimes.com/business/2026/02/12/novo-nordisk-set-to-make-wegovy-pill-in-ireland-for-markets-outside-us/
6. https://www.gurufocus.com/news/8611524/novo-nordisk-nvo-expands-irish-operations-for-wegovy-pill-production